Inclisiran Receives FDA Approval for New Indication to Treat HypercholesterolemiaI
Continue reading...
Inclisiran Receives FDA Approval for New Indication to Treat Hypercholesterolemia
Inclisiran Receives FDA Approval for New Indication to Treat Hypercholesterolemia
The FDA has approved a label update for inclisiran (Leqvio; Novartis Pharmaceuticals), allowing its use...